Top compounds associated with response to PSMD9


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.3
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA Axitinib CTRPv2 pan-cancer AAC -0.033 0.3
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.3
mRNA itraconazole CTRPv2 pan-cancer AAC -0.036 0.3
mRNA Mdivi-1 CTRPv2 pan-cancer AAC 0.035 0.3
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC -0.072 0.3
mRNA NSC632839 CTRPv2 pan-cancer AAC -0.032 0.3
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.032 0.3
mRNA BRD-K34485477 CTRPv2 pan-cancer AAC 0.071 0.3
Download CSV